Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Meier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|November 28, 2006
A note on the power of Fisher's least significant difference procedureUlrich Meier
Pharmaceutical Statistics|July 1, 2009
Nonparametric equivalence testing with respect to the median differenceUlrich Meier
Acta Neurochirurgica. Supplement|October 9, 2009
Does idiopathic normal pressure hydrocephalus always mean a poor prognosis?Michael Kiefer, Ulrich Meier, Regina Eymann
Contemporary Clinical Trials|May 25, 2005
A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trialsDavid B Hall, Ulrich Meier, Hans-Cristoph Diener
International Journal of Pharmaceutics|December 6, 2005
Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersionsGerhard Muhrer, Ulrich Meier, Francesco Fusaro, et al.
Applied Optics|November 8, 2005
Phase-locked two-line OH planar laser-induced fluorescence thermometry in a pulsating gas turbine model combustor at atmospheric pressureRobert Giezendanner-Thoben, Ulrich Meier, Wolfgang Meier, et al.
The New England Journal of Medicine|March 12, 2004
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraineJes Olesen, Hans-Christoph Diener, Ingo W Husstedt, et al.
AIDS (London, England)|December 20, 2007
Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scoresSharon L Walmsley, Laurent Cotte, Stefano Rusconi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51)Sharon L Walmsley, Christine Katlama, Adriano Lazzarin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2006
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trialStefan Schreiber, Brian Feagan, Geert D'Haens, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|November 28, 2006
A note on the power of Fisher's least significant difference procedureUlrich Meier
Pharmaceutical Statistics|July 1, 2009
Nonparametric equivalence testing with respect to the median differenceUlrich Meier
Acta Neurochirurgica. Supplement|October 9, 2009
Does idiopathic normal pressure hydrocephalus always mean a poor prognosis?Michael Kiefer, Ulrich Meier, Regina Eymann
Contemporary Clinical Trials|May 25, 2005
A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trialsDavid B Hall, Ulrich Meier, Hans-Cristoph Diener
International Journal of Pharmaceutics|December 6, 2005
Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersionsGerhard Muhrer, Ulrich Meier, Francesco Fusaro, et al.
Applied Optics|November 8, 2005
Phase-locked two-line OH planar laser-induced fluorescence thermometry in a pulsating gas turbine model combustor at atmospheric pressureRobert Giezendanner-Thoben, Ulrich Meier, Wolfgang Meier, et al.
The New England Journal of Medicine|March 12, 2004
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraineJes Olesen, Hans-Christoph Diener, Ingo W Husstedt, et al.
AIDS (London, England)|December 20, 2007
Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scoresSharon L Walmsley, Laurent Cotte, Stefano Rusconi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 8, 2008
Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51)Sharon L Walmsley, Christine Katlama, Adriano Lazzarin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2006
Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trialStefan Schreiber, Brian Feagan, Geert D'Haens, et al.
Pageof 2